Researchers Describe Potential Test for Early Stages of Mesothelioma

Will home remodeling projects lead to more cases of mesothelioma?
November 30, 2012
Asbestos and Mold Concerns Force Cleanup of Elementary School
December 27, 2012

We naturally like to look for a cause and effect when dealing with most things in our life. If we touch a hot pan, we feel pain and can see a red spot on our skin where we burned ourselves on the pan. Diseases like cancer can be a problem, because some cancers have long incubation periods, disconnecting the cause from the effect.

Mesothelioma is a deadly cancer that operates in this disturbing fashion. A person may be exposed to asbestos fibers years earlier, working in a shipyard, with electrical materials or handling plumbing or heating systems. They may appear healthy for many years, but then they begin to notice a cough, or perhaps they find themselves short of breath. They may ignore it, thinking it a cold or that they are not in as good shape physically as they once were.

Finally, they visit a doctor, and after tests, the find they have mesothelioma, and may only have months to live. Researchers at NYU School of Medicine published the results of a study in the New England Journal of Medicine that may give mesothelioma victims more hope.

The research shows promise of a potential early detection test for mesothelioma. The discovery of a protein product of a gene, which according to the lead researcher, “is present in levels four to five times higher in the plasma of patients with mesothelioma compared to levels in asbestos-exposed patients or patients with several other conditions that cause tumors in the chest.”

The researchers will be working to develop a diagnostic test base on this protein.

Source: NYU Langone Medical Center, “High Levels of Blood-Based Protein Specific to Mesothelioma,” October 10, 2012

June 28, 2024

Stem Cell Treatment Scams on the Rise

John Rodolf was convinced by an online advertisement to spend $6,000 at the Lung Institute in Tampa, Florida, in August 2015. The institute's website presented scientific studies and patient experiences as evidence that their innovative yet straightforward stem cell therapy could effectively manage chronic obstructive pulmonary disease (COPD).